昂利康: 关于监事减持股份的预披露公告

Group 1 - The company, Zhejiang Anglikang Pharmaceutical Co., Ltd., announced that its supervisor, Mr. Pan Xiaoyun, plans to reduce his shareholding by up to 159,000 shares, which represents 0.08% of the company's total share capital [1][2] - The reduction period is set from July 28, 2025, to October 27, 2025, following a 15 trading day notice period from the announcement date [1][2] - Mr. Pan holds a total of 638,635 shares, accounting for 0.32% of the company's total share capital, and 0.33% when excluding shares held in the repurchase account [1] Group 2 - The planned reduction will be executed through centralized bidding, and the number of shares to be reduced may be adjusted in case of any changes such as stock dividends or capital increases [2] - The company assures that the reduction plan complies with relevant laws and regulations, and there are no violations of commitments made by shareholders [2][3] - The company emphasizes that this share reduction will not significantly impact its governance structure, ownership structure, or future operations [3]